Walleye Capital LLC Novo Nordisk A S Put Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $17.1 Million - $20.9 Million	-143,600 Reduced 55.27%	116,200 $13.8 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $13 Million - $15.5 Million	105,800 Added 68.7%	259,800 $37.1 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $255,275 - $339,799	-2,500 Reduced 1.6%	154,000 $19.8 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $3.28 Million - $3.94 Million	37,400 Added 31.4%	156,500 $16.2 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $7.48 Million - $16.4 Million	82,300 Added 223.64%	119,100 $10.8 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $4.76 Million - $5.27 Million	30,500 Added 484.13%	36,800 $5.96 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $833,742 - $1 Million	6,300 New	6,300 $1 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $2.4 Million - $2.95 Million	25,200 New	25,200 $2.51 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.